Citation Tools
PDFRegular and Young Investigator Award Abstracts
Clinical Trials In Progress
725 Phase I safety and preliminary efficacy of PM8002 in subjects with advanced solid tumors, a bispecific antibody targeting PD-L1 and VEGF-A
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 725 Phase I safety and preliminary efficacy of PM8002 in subjects with advanced solid tumors, a bispecific antibody targeting PD-L1 and VEGF-A